Highlights
NASDAQ: ONCE       Spark Therap Cmn
Last Price Today's Change   Day's Range   Trading Volume
52.99   -2.63 (4.73%)  52.79 - 55.70  244,000

Overview

 
Avg Volume (4 weeks):269,663
4 Weeks Range:52.65 - 61.65
4 Weeks Price Volatility (%):
3.78%
52 Weeks Range:35.07 - 65.99
52 Weeks Price Volatility (%):
57.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.

  Be the first to like this.
 


 

3700  3395  893  405 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 JNS 14.17-0.08 
 BAC 23.24-0.01 
 DCTH 0.020.00 
 SPY 241.71-0.05 
 XLF 23.61-0.01 
 VXX 13.46-0.24 
 SIRI 5.29+0.17 
 XLK 56.38-0.03 
 AVP 3.41-0.14 
 GDX 22.94+0.23 
Partners & Brokers